EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS

The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients

AbbVie signals major oncology momentum at ASCO

With standout ADC and t-cell engager response data across hard-to-treat cancers

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond

National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform

NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro

Decoding teleophthalmology role in transforming last-mile eye care in India

By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic

HVS Hospitals records highest advanced clip therapy procedures in western India

The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications

Novo Nordisk unveils breakthrough MASH data as ‘silent’ liver disease threatens 250 million